Literature DB >> 10219438

Endoscopic sinus surgery for rhinocerebral mucormycosis.

R S Jiang1, C Y Hsu.   

Abstract

Rhinocerebral mucormycosis is a fulminant, often fatal, disease. Aggressive surgical debridement has been considered an important part of treatment. Traditionally, an external or transantral approach has been the classic method. Recently, endoscopic sinus surgery (ESS) has been tried on several occasions to reach the goal of radical resection. Since 1991, ESS has been used to treat 9 rhinocerebral mucormycosis patients in our department. Among them, ESS was the only surgical procedure in six patients. The other three patients were treated by ESS combined with a transantral procedure. As a result, eight patients (88.9%) have survived the disease. One patient died 5 days after ESS because of an internal carotid artery occlusion. We conclude that ESS can be used to treat rhinocerebral mucormycosis alone or in combination with the traditional surgical procedures. It has the advantage of less operative morbidity and greater operative accuracy.

Entities:  

Mesh:

Year:  1999        PMID: 10219438     DOI: 10.2500/105065899782106751

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  7 in total

1.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

2.  Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID-19 Pandemic: A Case-Control Study.

Authors:  Laleh Dehghanpisheh; Mohammadhossein Eghbal; Mehrdad Salari; Reza Shahriarirad; Niloofar Borzou; Pooya Vatankhah
Journal:  Int J Clin Pract       Date:  2022-06-07       Impact factor: 3.149

Review 3.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

4.  Rhinocerebral mucormycosis: A deadly disease on the rise.

Authors:  R S Mane; J K Watve; A A Mohite; B C Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-09-14

5.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

6.  Functional Endoscopic Sinus Surgery and Recurrence of Post-COVID Mucormycosis.

Authors:  B M Rudagi; Jay Goyal; Chinmayee Palande; Prachi Patil
Journal:  J Maxillofac Oral Surg       Date:  2022-10-11

7.  Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis.

Authors:  Harun Gür; Onur İsmi; Yusuf Vayısoğlu; Kemal Görür; Rabia Bozdoğan Arpacı; Elif Şahin Horasan; Cengiz Özcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-01       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.